GR3036660T3 - Sulphuric acid esters of sugar alcohols for the inhibition of the migration and proliferation of smooth muscle cells of the vascular walls - Google Patents

Sulphuric acid esters of sugar alcohols for the inhibition of the migration and proliferation of smooth muscle cells of the vascular walls

Info

Publication number
GR3036660T3
GR3036660T3 GR20010401520T GR20010401520T GR3036660T3 GR 3036660 T3 GR3036660 T3 GR 3036660T3 GR 20010401520 T GR20010401520 T GR 20010401520T GR 20010401520 T GR20010401520 T GR 20010401520T GR 3036660 T3 GR3036660 T3 GR 3036660T3
Authority
GR
Greece
Prior art keywords
proliferation
migration
inhibition
acid esters
smooth muscle
Prior art date
Application number
GR20010401520T
Other languages
English (en)
Inventor
Alexander Chucholowski
Michael Pech
Juergen Fingerle
Marianne Rouge
Niggi Iberg
Gerard Schmid
Hans Peter Maerki
Thomas Tschopp
Rita Mueller
Hans Peter Wessel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of GR3036660T3 publication Critical patent/GR3036660T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/06—Hydrogenosulfates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/10—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated being further substituted by singly-bound oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
GR20010401520T 1995-05-05 2001-09-18 Sulphuric acid esters of sugar alcohols for the inhibition of the migration and proliferation of smooth muscle cells of the vascular walls GR3036660T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH131095 1995-05-05

Publications (1)

Publication Number Publication Date
GR3036660T3 true GR3036660T3 (en) 2001-12-31

Family

ID=4207454

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401520T GR3036660T3 (en) 1995-05-05 2001-09-18 Sulphuric acid esters of sugar alcohols for the inhibition of the migration and proliferation of smooth muscle cells of the vascular walls

Country Status (15)

Country Link
US (1) US5830920A (el)
EP (1) EP0741128B1 (el)
JP (1) JP2881752B2 (el)
CN (1) CN1150589A (el)
AR (1) AR003945A1 (el)
AT (1) ATE202339T1 (el)
BR (1) BR9602148A (el)
CA (1) CA2174583A1 (el)
DE (1) DE59607115D1 (el)
DK (1) DK0741128T3 (el)
ES (1) ES2160190T3 (el)
GR (1) GR3036660T3 (el)
MX (1) MX9601521A (el)
PT (1) PT741128E (el)
TR (1) TR199600329A2 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001053275A2 (de) * 2000-01-17 2001-07-26 Bayer Aktiengesellschaft Substituierte arylketone
ES2241867T3 (es) 2000-09-07 2005-11-01 Telik, Inc. Amidas del acido bencenotricarboxilico como activadores del receptor de insulina.
US7354747B1 (en) * 2003-05-08 2008-04-08 The Regents Of The University Of California Carbohydrate derived protein resistant biomaterial
JP5731406B2 (ja) * 2009-01-29 2015-06-10 ザ ジェネラル ホスピタル コーポレイション クロモリン誘導体、クロモリン誘導体を用いた治療方法及び造影方法
US9925282B2 (en) 2009-01-29 2018-03-27 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
CN109846862A (zh) 2012-10-25 2019-06-07 通用医疗公司 治疗阿尔茨海默病及相关疾病的组合疗法
US10058530B2 (en) 2012-10-25 2018-08-28 The General Hospital Corporation Combination therapies for the treatment of Alzheimer's disease and related disorders
US10525005B2 (en) 2013-05-23 2020-01-07 The General Hospital Corporation Cromolyn compositions and methods thereof
AU2014340182B2 (en) 2013-10-22 2019-05-23 The General Hospital Corporation Cromolyn derivatives and related methods of imaging and treatment
WO2015151068A1 (en) * 2014-04-03 2015-10-08 Universita' Di Pisa Synthetic analogues of 3-iodothyronamine (t1am) and uses thereof
GEP20186887B (en) 2014-04-04 2018-08-27 Pfizer Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
CN116889562A (zh) 2016-08-31 2023-10-17 通用医疗公司 与神经退行性疾病相关的神经炎症中的巨噬细胞/小胶质细胞
WO2019017995A1 (en) 2017-07-20 2019-01-24 Aztherapies, Inc. FORMULATIONS OF CROMOLYNE SODIUM POWDER AND IBUPROFEN
KR20210071943A (ko) 2018-07-02 2021-06-16 더 제너럴 하스피탈 코포레이션 크로몰린 소듐 및 α-락토스의 분말화된 제형
KR20210071974A (ko) * 2018-09-05 2021-06-16 더 제너럴 하스피탈 코포레이션 사이토카인 방출 증후군을 치료하는 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
DE3101376A1 (de) * 1981-01-17 1982-09-02 Bayer Ag, 5090 Leverkusen Sisomicin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB8612940D0 (en) * 1986-05-28 1986-07-02 Dow Chemical Co Derivative esters
DE3734853A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Bis-aldonsaeureamide und verfahren zu ihrer herstellung
DE3734815A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Polyschwefelsaeureester von bis-aldonsaeureamiden und deren derivaten, verfahren zu ihrer herstellung und arzneimittel
US5298616A (en) * 1990-10-03 1994-03-29 Hoffmann-La Roche Inc. Sulfated O-polysaccharide-trehaloses
CA2061370A1 (en) * 1991-03-13 1992-09-14 Markus Hosang Pharmaceutical preparations
TW308598B (el) * 1994-01-14 1997-06-21 Hoffmann La Roche

Also Published As

Publication number Publication date
JPH08301839A (ja) 1996-11-19
CA2174583A1 (en) 1996-11-06
DE59607115D1 (de) 2001-07-26
DK0741128T3 (da) 2001-10-15
EP0741128B1 (de) 2001-06-20
PT741128E (pt) 2001-11-30
US5830920A (en) 1998-11-03
EP0741128A2 (de) 1996-11-06
ATE202339T1 (de) 2001-07-15
BR9602148A (pt) 2005-06-21
TR199600329A2 (tr) 1997-03-21
AR003945A1 (es) 1998-09-30
MX9601521A (es) 1997-02-28
ES2160190T3 (es) 2001-11-01
JP2881752B2 (ja) 1999-04-12
CN1150589A (zh) 1997-05-28
EP0741128A3 (de) 1997-03-26

Similar Documents

Publication Publication Date Title
GR3036660T3 (en) Sulphuric acid esters of sugar alcohols for the inhibition of the migration and proliferation of smooth muscle cells of the vascular walls
EP0752885A4 (en) THERAPEUTIC INHIBITOR OF SMOOTH VASCULAR MUSCLE CELLS
SG65631A1 (en) Preparation of acrylic acid and esters
PT85908A (en) Cross-linked esters of hyaluronic acid
AU9164198A (en) Use of organic acid esters in dietary fat
GB2163149B (en) Process for the preparation of esters of acrylic and methacrylic acid
PL331700A1 (en) Method of obtaining fatty acid esters
HK1010970A1 (en) Ridged dough structure and method of making the ridged dough structure
AU4983396A (en) Inhibition of proliferation of vascular smooth muscle cell
EP0590401A3 (en) Fatty acid ester of cellulose, cellulose diacetate and processes for the preparation thereof
PL322652A1 (en) Compounds of pyrolydinylohydroxamic acid and method of obtaining them
PL312027A1 (en) Quaternary triethylamine fatty acid esters and method of obtaining them
IL89443A0 (en) Inhibition of intestinal cholesterol and fatty acid absorption
ZA946065B (en) Process for the removal of lead and cadmium form phosphoric acid
GB9517043D0 (en) The use of bile acid derivatives
AU4862996A (en) Il-12 inhibition of b1 cell activity
AU9082591A (en) Method of propagating human paramyxoviruses using continuous cell lines
PL333247A1 (en) Method of manufacturing of salts and esters of clavulan acid
ZA961843B (en) Process for the preparation of esters of stilbenedi-carboxylic acid
AU2797289A (en) Dietary supplement and method for the treatment of menopause and manifestations of aging
GB2162516B (en) Process for the preparation of esters of acrylic and methacrylic acid
IL122919A (en) Preparation of 1-alkyl-pyrazole-5- carboxylic acid esters
PL323148A1 (en) Esters of crabapenemes
AU551185B2 (en) Alkoxy-vincaminic acid and apovincaminic acid esters
PL323141A1 (en) Esters of crabapenemes

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees